🇺🇸 IV Lidocaine in United States

20 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain Upper — 2 reports (10%)
  2. Arthralgia — 2 reports (10%)
  3. Blood Cholesterol Increased — 2 reports (10%)
  4. Dyspnoea — 2 reports (10%)
  5. Headache — 2 reports (10%)
  6. Lip Discolouration — 2 reports (10%)
  7. Low Density Lipoprotein Increased — 2 reports (10%)
  8. Muscle Spasms — 2 reports (10%)
  9. Musculoskeletal Stiffness — 2 reports (10%)
  10. Myalgia — 2 reports (10%)

Source database →

Frequently asked questions

Is IV Lidocaine approved in United States?

IV Lidocaine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for IV Lidocaine in United States?

University of Washington is the originator. The local marketing authorisation holder may differ — check the official source linked above.